Therefore, we hypothesized that TRAIL resistance in cancer cells can be overcome by reversing the mechanisms by which TRAIL resistance is established, such as by upregulating DR4 and DR5, overexpressing pro-apoptotic proteins, downregulating anti-apoptotic proteins, and inhibiting key factors that regulate cell survival. Here, TNFRSF10A is linked to cancer.